Abiomed is a leading medical device company that specializes in developing advanced heart support technologies. The company is headquartered in Danvers, Massachusetts, and has been in operation for over 30 years. Abiomed’s mission is to improve patient outcomes and quality of life by developing innovative heart recovery technologies that enable patients to recover more quickly and return to normal activities.
One of Abiomed’s most successful products is the Impella heart pump, a miniature pump that can be implanted directly into the heart to provide temporary circulatory support during procedures such as heart surgery or angioplasty. The Impella pump is designed to improve blood flow and reduce the workload on the heart, allowing the heart to rest and recover. The Impella has been used in thousands of procedures around the world and has been shown to significantly improve patient outcomes and reduce the risk of complications.
Abiomed has a strong commitment to innovation and research, investing heavily in developing new technologies and advancing the field of heart recovery. The company has a team of world-class engineers and researchers who work tirelessly to design and test new devices that can improve patient outcomes and reduce the burden on healthcare providers. Abiomed’s dedication to innovation has led to numerous breakthroughs in the field of heart recovery, and the company continues to push the boundaries of what is possible in this important area of medicine.
Abiomed Medical Devices
1 – Impella ECP
Impella ECP is a medical device used for temporary mechanical circulatory support in patients with reduced heart function. It is designed to increase blood flow and relieve stress on the heart, especially during high-risk procedures or while waiting for a heart recovery or transplant.
The Impella ECP device is a miniaturized heart pump that is inserted into the left ventricle of the heart via a catheter. The device consists of a small motor that drives a flexible micro axial pump, which can generate up to 3.5 liters of blood flow per minute. The device is capable of providing full circulatory support for up to four days, allowing time for the heart to recover or for other interventions to be performed.
The Impella ECP is approved by the US Food and Drug Administration (FDA) for use in patients with severe heart failure or cardiogenic shock, as well as during high-risk percutaneous coronary interventions (PCI) or transcatheter aortic valve replacement (TAVR) procedures.
2 – AbioCor
AbioCor is a type of artificial heart developed by Abiomed, Inc., a medical technology company based in Massachusetts, United States. The AbioCor heart is designed to replace a patient’s failing heart completely, functioning as a permanent solution rather than a temporary measure like many other heart assist devices.
The AbioCor heart is implanted directly into the patient’s chest and is powered by an external battery pack worn by the patient. It operates using a combination of hydraulic and electrical systems to mimic the functions of a natural heart. The device is small enough to fit inside a patient’s chest cavity and is designed to be implanted without requiring the removal of the patient’s own heart.
The AbioCor heart is a breakthrough in the field of cardiac medicine, providing hope to patients suffering from severe heart failure who may not be suitable candidates for heart transplantation. The device has been approved for use by the US Food and Drug Administration (FDA) under a Humanitarian Use Device (HUD) designation, which means it can be used to treat patients with life-threatening conditions for which there are no other treatment options available.
Medical Device Lists
- Impella ECP